Difference between revisions of "NCCN guidelines"
Jump to navigation
Jump to search
| Line 27: | Line 27: | ||
*'''2007:''' Crawford et al. [https://doi.org/10.6004/Jnccn.2007.0019 Myeloid growth factors. Clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/17335688/ PubMed] | *'''2007:''' Crawford et al. [https://doi.org/10.6004/Jnccn.2007.0019 Myeloid growth factors. Clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/17335688/ PubMed] | ||
*'''2005:''' Crawford et al. [https://doi.org/10.6004/Jnccn.2005.0030 Myeloid growth factors clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/16038645/ PubMed] | *'''2005:''' Crawford et al. [https://doi.org/10.6004/Jnccn.2005.0030 Myeloid growth factors clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/16038645/ PubMed] | ||
| + | |||
| + | =Fatigue= | ||
| + | *'''2010:''' Berger et al. [https://doi.org/10.6004/Jnccn.2010.0067 NCCN Clinical Practice Guidelines Cancer-related fatigue.] [https://pubmed.ncbi.nlm.nih.gov/20870636/ PubMed] | ||
Revision as of 17:03, 30 November 2023
This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page.
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.
Miscellaneous
- 2003: Unknown et al. Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology. PubMed
- 2015: Bevers et al. Breast Cancer Risk Reduction, Version 2.2015. PubMed
- 2003: Unknown et al. Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology. PubMed
- 2018: Bevers et al. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. PubMed
Middle East and North Africa
- 2010: Abulkhair et al. Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region. PubMed
- 2010: Içli et al. Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region. PubMed
- 2010: Yusuf et al. Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region. PubMed
- 2010: Bazarbachi et al. Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region. PubMed
- 2010: Jazieh et al. Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region. PubMed
- 2010: Shamieh et al. Modification and implementation of NCCN Guidelines on palliative care in the Middle East and North Africa region. PubMed
- 2010: Hassen et al. Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region. PubMed
Myeloid Growth Factor
- 2013: Crawford et al. Myeloid growth factors. PubMed
- 2011: Crawford et al. Myeloid growth factors. PubMed
- 2009: Crawford et al. Myeloid growth factors. PubMed
- 2007: Crawford et al. Myeloid growth factors. Clinical practice guidelines in oncology. PubMed
- 2005: Crawford et al. Myeloid growth factors clinical practice guidelines in oncology. PubMed
Fatigue
- 2010: Berger et al. NCCN Clinical Practice Guidelines Cancer-related fatigue. PubMed